YANG QU: Open Payments
NPI 1205457900 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 119 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,427 · 2025 $2,757
Food & beverage: $2,647Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $588 |
| Janssen Biotech, Inc. | 23 | $578 |
| Organon LLC | 13 | $449 |
| Regeneron Healthcare Solutions, Inc. | 7 | $201 |
| Arcutis Biotherapeutics, Inc. | 9 | $197 |
| PFIZER INC. | 19 | $171 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $164 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| GENZYME CORPORATION | 2 | $68 |
| Galderma Laboratories, L.P. | 4 | $63 |
Products named: TREMFYA, SKYRIZI, RINVOQ, HADLIMA, Zoryve, CIBINQO, ILUMYA, VTAMA.
Industry payments across WA — which companies pay providers there.
